|
Stada Arzneimittel AG - Company Profile Snapshot
| Company Profile: |
Stada Arzneimittel AG |
| Ticker: |
SAZ3 |
| Exchanges: |
FRA OTH |
| 2008 Sales: |
1,646,200,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| Country: |
GERMANY |
| Employees: |
8318 |
Business Description
Stada Arzneimittel AG(STADA). The Group's principal activity is to manufacture generic drugs. The Group operates through two core segments: Generics and Branded products. Through Generics segment, the Group offers medicines after the expiration of their patents at the same quality but for significantly lower prices. Through Branded Products segment, the Group focuses on multisource products with off-patent active ingredients. The Group's current branded products portfolio includes primarily non-prescription which are called over-the-counter products (OTC products), and in some national markets also prescription drugs. The non-core segment includes commercial business. The Group mainly operates in Europe, America and Asia.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
